ifosfamide has been researched along with Cancer of the Ureter in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshinaga, A | 1 |
| Kamata, S | 1 |
| Kitamura, H | 1 |
| Taguchi, K | 1 |
| Kunishima, Y | 1 |
| Yanase, M | 1 |
| Takahashi, A | 1 |
| Shigyo, M | 1 |
| Tanaka, T | 1 |
| Mutoh, M | 1 |
| Fukuta, F | 1 |
| Masumori, N | 1 |
| Tsukamoto, T | 1 |
| Kyriakakis, Z | 1 |
| Dimopoulos, MA | 1 |
| Kostakopoulos, A | 1 |
| Karayiannis, A | 1 |
| Sofras, F | 1 |
| Zervas, A | 1 |
| Giannopoulos, A | 1 |
| Dimopoulos, C | 1 |
2 trials available for ifosfamide and Cancer of the Ureter
| Article | Year |
|---|---|
Paclitaxel, ifosfamide, and nedaplatin as second-line treatment for patients with metastatic urothelial carcinoma: a phase II study of the SUOC group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Disease-F | 2011 |
Cisplatin, ifosfamide, methotrexate and vinblastine combination chemotherapy for metastatic urothelial cancer.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic A | 1997 |
1 other study available for ifosfamide and Cancer of the Ureter
| Article | Year |
|---|---|
[Long survival in a patient with advanced ureteral carcinoma treated with TIN regimen (paclitaxel, ifosfamide, nedaplatin) and radiotherapy : a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Humans; Ifosfamide; Male; N | 2014 |